FDA Drug Application (022173) for ZYPREXA RELPREVV by ELI LILLY CO

Back to FDA Applications sponsored by ELI LILLY CO

Application Number022173
Product Number001
FormSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
DosageEQ 210MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZYPREXA RELPREVV
Active IngredientOLANZAPINE PAMOATE



Back to FDA Applications sponsored by ELI LILLY CO

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.